| Subject: |
|
Re: Zyprexa: Not The Only Lilly Lie |
| Name: |
|
Melody |
| Date Posted: |
|
Dec 18, 06 - 3:54 PM |
| IP Address: |
|
4.235.87.25 |
| Email: |
|
otchmoson@mindspring.com |
| Website: |
|
http://www.tooprofitabletocure.com |
| Message: |
|
Great post--what most "ostriches" won't recognize is that Lilly's marketing strategy for rDNA human insulin laid the groundwork--become the company standard--for Lilly's decades' long business model.
1. Lie, obfuscate, deny, misdirect
2. "Educate" MDs about off-label uses; provide with catchy slogans (Why would a human being want to use anything BUT human insulin?)
3. Blame (kill) the messenger; anyone who challenges the "diabetes expert known as Eli Lilly" is quack-material
4. Repeat steps 1, 2 & 3. [It worked for rDNA insulin; it worked for Prozac; it worked (until now, at least) for Zyprexa.]
 |
|
|
|
|
|
|
Reply
Home
bravenet.com